UK Markets close in 4 hrs 36 mins

EVOTEC SE (EVT.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
44.880.00 (0.00%)
As of 11:55AM CEST. Market open.
Full screen
Previous close44.88
Open44.86
Bid45.05 x 145200
Ask45.28 x 140700
Day's range44.77 - 44.98
52-week range22.58 - 45.70
Volume25
Avg. volume89
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Evotec SE files registration statement for proposed offering of American Depositary Shares

    DGAP-News: Evotec SE / Key word(s): Miscellaneous11.10.2021 / 07:30 The issuer is solely responsible for the content of this announcement.Hamburg, Germany, 11 October 2021:Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed offering and sale in the United States of shares of Evotec represented by American Depositary Shares (

  • EQS Group

    Evotec expands neuroscience collaboration with Bristol Myers Squibb to include novel cell type

    DGAP-News: Evotec SE / Key word(s): Miscellaneous08.10.2021 / 07:30 The issuer is solely responsible for the content of this announcement. INCLUDES NEW CELL TYPES FOR STUDYING MOLECULAR DISEASE SIGNATURES FOR DISCOVERY OF DISEASE-MODIFYING THERAPIES FOR NEURODEGENERATIVE DISEASES TRIGGERS US$ 9.0 M PAYMENT TO EVOTECHamburg, Germany, 08 October 2021:Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that its collaboration with Bristol Myers Squibb (NYSE: BM

  • EQS Group

    Just - Evotec Biologics opens J.POD 1 US in Redmond, Washington

    DGAP-News: Evotec SE / Key word(s): Miscellaneous11.08.2021 / 07:30 The issuer is solely responsible for the content of this announcement. J.POD(R) 1 US PROVIDES UNIQUELY FLEXIBLE CGMP MANUFACTURING OF KILOGRAMS TO METRIC TONS OF BIOLOGICS THERAPEUTICS J.POD(R) FACILITY EXPANDS JUST - EVOTEC BIOLOGICS' CAPABILITIES INTO COMMERCIAL BIOLOGICS MANUFACTURING AND ADDS LATE STAGE CLINICAL DEVELOPMENT AND COMMERCIAL SUPPLY FOR BOTH SMALL AND LARGE QUANTITIES OF DRUG SUBSTANCEHamburg, Germany, 11 August